Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News

Pfizer Offloads $3B Stake in Consumer Healthcare Giant Haleon, Reducing Position to 7.3%

by Team Lumida
January 15, 2025
in News
Reading Time: 2 mins read
A A
0
Pfizer’s $43 Billion Gamble: What It Means for Cancer Research

"Pfizer Booth at the CCC 2006 in Vancouver" by colros is licensed under CC BY 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com
• Sale valued at £2.50B ($3.05B) at 357 pence per share
• Pfizer’s stake reduces from 15% to 7.3%
• Transaction follows GSK’s complete exit in May 2024

What Happened?

Pfizer has executed a major share sale in Haleon, the consumer healthcare company that owns prominent brands like Sensodyne and Advil. The pharmaceutical giant sold 700 million shares at 357 pence each, representing a 2.75% discount to market price. This transaction reduces Pfizer’s ownership from 15% to 7.3% in Haleon, which was created through the 2019 merger of GSK and Pfizer’s consumer healthcare divisions before its 2022 London Stock Exchange listing.

Why It Matters?

This divestment represents a significant shift in Pfizer’s investment strategy and relationship with Haleon. The sale follows GSK’s complete exit in May 2024, suggesting both founding partners are gradually reducing their exposure to the consumer healthcare business. The transaction’s timing and size indicate Pfizer’s potential focus on core pharmaceutical operations and capital reallocation strategies, while also providing substantial liquidity.

What’s Next?

Investors should watch for Pfizer’s deployment of the $3.05 billion in proceeds and any signals regarding its plans for the remaining 7.3% stake in Haleon. The market will also be monitoring Haleon’s performance as an increasingly independent entity, free from its founding partners’ significant influence. The discount offered in this sale might impact Haleon’s short-term share price movements and market perception.

Source
Previous Post

US Population Growth Set to Stall as Deaths Expected to Exceed Births by 2033

Next Post

China’s Central Bank Injects $130.9B in Near-Record Liquidity Move Amid Yuan Support Efforts

Recommended For You

US Gaza Plan Is Working, But Will Take Sustained Pressure

by Team Lumida
12 hours ago
US Gaza Plan Is Working, But Will Take Sustained Pressure

Key Takeaways Powered by lumidawealth.com The Trump administration’s plan has created diplomatic momentum and a realistic path for an initial hostage‑for‑prisoner swap, but broader settlement mechanics remain unresolved. Core...

Read more

Boeing Said to Prepare for 737 Output Hike

by Team Lumida
13 hours ago
a tall building with a sign on top of it

Key Takeaways Powered by lumidawealth.com Boeing is guiding suppliers that 737 Max production could rise to 42 jets/month as soon as October, with further pushes planned (targeting ~53/month by...

Read more

China Secretly Funds Iranian Oil via Infrastructure

by Team Lumida
13 hours ago
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

Key Takeaways Powered by lumidawealth.com Beijing is using a covert barter‑style conduit to pay Iran for crude: oil shipments to China are effectively financed by Chinese state‑backed contractors building...

Read more

Trump Pushes for Israel–Hamas Deal Ahead of Monday Talks

by Team Lumida
13 hours ago
Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Key Takeaways Powered by lumidawealth.com The U.S. is pressing Israel and Hamas toward mediated talks in Sharm El‑Sheikh focused initially on a hostage‑for‑prisoner swap and a ceasefire framework. Core...

Read more

Gold, Bitcoin Surge on Global Debt Concerns

by Team Lumida
13 hours ago
Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Key Takeaways Powered by lumidawealth.com Gold and Bitcoin hit fresh highs as investors rotate into “debasement” hedges amid rising fiscal concerns across major economies (U.S., Japan, Europe). The yen...

Read more

Terraformation’s Tree‑Subscription Service

by Team Lumida
2 days ago
A cell phone sitting on top of a wooden table

Key Takeaways Powered by lumidawealth.com Terraformation (founded by former Reddit CEO Yishan Wong) launched a $25/month subscription that funds planting and multi‑year care for biodiverse forests, with initial projects...

Read more

China Pushes Trump to Ease Security Curbs in Exchange for Investment

by Team Lumida
2 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways Powered by lumidawealth.com Beijing has floated a proposal to the U.S. asking Washington to roll back national‑security barriers to Chinese investment in the U.S. in return for...

Read more

Lawsuit Challenges Trump’s $100,000 H‑1B Fee

by Team Lumida
2 days ago
Trump Delays Reciprocal Tariffs to August 1, Citing Progress in Trade Negotiations

Key Takeaways Powered by lumidawealth.com A coalition led by healthcare‑staffing firm Global Nurse Force and several labor unions filed suit in the Northern District of California to block the...

Read more

Bitcoin Climbs to $120K as Safe‑Haven & ETF Flows Drive Rally

by Team Lumida
4 days ago
Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Key Takeaways Powered by lumidawealth.com Bitcoin rose to about $120,000, the highest since its recent record, extending a six‑day rally and gaining ~10% since last Friday. Week‑to‑date spot‑ETF inflows...

Read more

Boeing to Take Billions in Charges After 777X Delay

by Team Lumida
4 days ago
a tall building with a sign on top of it

Key Takeaways Powered by lumidawealth.com Boeing’s 777X certification and entry‑into‑service have slipped further, now expected in 2027 (early or H2 depending on the read), prompting analysts to forecast a...

Read more
Next Post
China’s Bold Economic Moves: What You Need to Know Now

China's Central Bank Injects $130.9B in Near-Record Liquidity Move Amid Yuan Support Efforts

high-rise building during nighttime

NYC's Congestion Pricing Shows Early Success with 8% Traffic Drop, but Businesses Feel the Pinch

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Jamie Dimon Calls Private Credit Dangerous, Yet JPMorgan Commits $50 Billion to Enter Market

Jamie Dimon Calls Private Credit Dangerous, Yet JPMorgan Commits $50 Billion to Enter Market

July 14, 2025
Citigroup Q2 2024 Earnings Summary

Citigroup Q2 2024 Earnings Summary

July 12, 2024

Global Markets End 2024 Strong: S&P 500 Up 24%, Dollar Posts Best Year Since 2015

December 31, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018